MedPath
NMPA Approval

Latanoprost Eye Drops

国药准字HJ20230111

August 28, 2024

Drug Information

拉坦前列素滴眼液

眼用制剂

0.005%(2.5ml:125μg)

化学药品

August 28, 2024

September 18, 2028

Company Information

Applicant Company

Calle Copenhague 12, Oficina 205, Edificio Tifán, 28232 Las Rozas, Madrid, Spain

Manufacturing Company

RAFARM S.A.

Thesi Pousi-Xatzi Agiou Louka,19002 Paiania, Attiki, Greece

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉坦前列素滴眼液 - NMPA 批准文号 | MedPath